alexa Oncogenic Pathways in the Development of Oral Cancer | OMICS International
ISSN: 2157-2518
Journal of Carcinogenesis & Mutagenesis
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Oncogenic Pathways in the Development of Oral Cancer

Rui Amaral Mendes RA*

Department of Oral Medicine/Oncology and Clinical Pathology, Portuguese Catholic University, Portugal

*Corresponding Author:
Rui Amaral Mendes RA
Department of Oral Medicine/ Oncology and Clinical Pathology Portuguese Catholic University, Portugal
Tel: +351-93-2805962
E-mail: [email protected]

Received date: December 18, 2012; Accepted date: December 19, 2012; Published date: December 28, 2012

Citation: Mendes RA RA (2012) Oncogenic Pathways in the Development of Oral Cancer. J Carcinogene Mutagene 3:133. doi: 10.4172/2157-2518.1000133

Copyright: © 2012 Mendes RA RA. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Carcinogenesis & Mutagenesis


Oral carcinogenesis is a molecular and histological multistage process featuring genetic and phenotypic markers for each stage, which involves enhanced function of several oncogenes and/or the deactivation of tumor suppressor genes, resulting in the loss of cell cycle checkpoints.

Oral carcinogenesis is a molecular and histological multistage process featuring genetic and phenotypic markers for each stage, which involves enhanced function of several oncogenes and/or the deactivation of tumor suppressor genes, resulting in the loss of cell cycle checkpoints.

The progression towards malignancy includes sequential histopathological alterations ranging from hyperplasia through dysplasia to carcinoma in situ and invasive carcinoma, which are determined by the accumulation of a series of genetic events. In cellular carcinogenesis, various genes interact with each other, thus leading to multiple alterations that occur in a rather complex way and in different stages of progression of the disease [1].

Several signal transduction pathways have been reported to be altered in cancer, leading to dramatic changes in cell survival, cell proliferation, morphology, angiogenesis, longevity and other properties, which characterize cancer cells.

Epidermal Growth Factor Receptor (EGFR), one of the best studied oncogenes, plays an important role in the control of cellular proliferation, apoptosis, invasion, angiogenesis, and metastasis, as it works through the tyrosine kinase cascade. This receptor tyrosine kinase, also known as type I receptor tyrosine kinases or ErbB tyrosine kinase receptors, has many downstream signaling targets associated with carcinogenesis. Once phosphorylated, the receptor can signal via the MAPK, Akt, ERK, and Jak/STAT pathways.

Abnormality of EGFR gene and overexpression of the protein have been reported in various human tumors, with an abnormal amplification of the EGFR gene being reported in oral squamous cell carcinoma, although not limited to the final stages of the carcinogenic process. In fact, a low level of gene amplification also occurs at a significant frequency in epithelial dysplasia and carcinoma in situ, and, moreover, increased EGFR gene copies via amplification seems to play an important role in the development of invasive cancer [2].

Moreover, the expression of proliferation markers TGF-α and EGFR in cells of the oral epithelium presenting a spectrum of dysplastic changes revealed a serial upregulation both in terms of area and intensity of staining of TGF-α in the epithelial cells of oral precancerous lesions exhibiting features of dysplasia. Likewise, TGF-α expression has been reported higher than EGFR’s in the proliferative pool of the oral epithelium in oral precancer lesions, thus suggesting that an initial upregulation of TGF-α was likely to exert a paracrine effect on the adjacent nonproliferative cells therefore increasing the expression of the cell surface receptor [3].

Significant linear increase in the intensity of staining of EGFR in the differentiated cells of the stratum spinosum in oral leukoplakia with mild epithelial dysplasia has also been reported, which might be explained by the inducing role of TGF-α over DNA synthesis in noncycling cells [3].

These data not only support that increased dysregulation of epithelial cell growth is associated with increasing degrees of dysplasia, but are also suggestive of increased receptor-ligand interaction with increasing degrees of dysplasia.

Activation of the PI3K-AKT signal pathway may seems to be also closely related to oral precancerous lesions, with a genetic mutation being generated at a relatively early stage of cancer [4].

Additionally, PTEN, a dual protein/lipid phosphatase whose main substrate - phosphatidyl-inositol 3,4,5 triphosphate (PIP3) - is the product of PI3K, may be mutated or epigenetically inactivated in a large fraction of human tumors, rivaling with p53 as one of the most important tumor suppressor proteins. PTEN activity may be lost by mutations, deletions or promoter methylation silencing [5].

In oral cancer, genetic alterations in PTEN, located at 10q23.3, occur in 5-10% of oral squamous cell carcinoma lesions but, remarkably, loss of PTEN expression was observed by Lee et al. in up to 29% oral squamous cell carcinomas of the tongue. This lack of PTEN expression may be an independent prognostic indicator of poor clinical outcome [6].

Moreover, chronic inflammation has been known to induce neoplasia through the increased production of reactive oxygen and nitrogen species, which results in elevated DNA damage. Moreover, it may induce the expression of multiple tumor-promoting genes, such as the tumor necrosis factor gene (TNF), matrix metalloproteinases (MMP) genes, and vascular endothelial growth factor (VEGF) genes which contribute to enhanced cellular migration and angiogenesis through the regulation of the proinflammatory gene Nuclear Factor ?B (NF?B) [7].

On the other hand, tumor-promoting phorbol esters induce COX- 2 gene expression by activating the protein-kinase C (PKC) pathway, with one of the downstream target of activated PKC being the AP-1 transcription factor complex [8].

Single nucleotide polymorphisms of COX-2 have also been associated with the risk of multiple cancers, with the first epidemiologic evidence indicating that potentially functional polymorphisms of the COX-2 gene may have an impact on individual susceptibility to oral premalignant lesions [9].

Furthermore, angiogenesis is crucial to the growth, invasion and metastasis of a tumour and a significant increase in vascularity occurs during the transition from normal oral mucosa, through differing degrees of dysplasia, to invasive squamous cell carcinoma.

Although studies involving the expression of VEGF dysplastic epithelium are somehow conflicting, VEGF expression was found to correlate with the degree of tumour differentiation, which is consistent with the results of previous studies, although the reason why the expression of VEGF appears to be reduced in poorly differentiated oral squamous cell carcinoma still remains unclear [10-12].

Interestingly, a study which assessed whether there were any gene amplifications ocurring in oral dysplasias and, most importantly, which were the oncogenic pathways disrupted in premalignancies, found out that gene amplification did occur in 40% of the early lesions but, most importantly, that affected genes were part of different canonical oncogenic pathways, of which they were able to identify 5, which share common nodes and interact as a single network [13].

According to the histological model of oral carcinogenesis, cells chronically exposed to environmental carcinogens progress through the stages of reactive hyperkeratosis, epithelial hyperplasia, degrees of dysplasia and intraepithelial carcinoma leading to invasive carcinoma.

Comprehension of the underlying pathways governing the progression of oral premalignant lesions is of the utmost importance. The molecular changes antedate the occurrence of invasive malignancy and can be used for risk assessment and as intermediate endpoints for targeted therapies.

Focus on preinvasive stages of high-grade and low-grade lesions that are known to further develop into cancer will allow us to identify early genetic events during cancer development, as genetic alterations build up a neoplastic phenotype.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 12045
  • [From(publication date):
    December-2012 - Apr 25, 2018]
  • Breakdown by view type
  • HTML page views : 8183
  • PDF downloads : 3862

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version